Trial Details

Not Recruiting
Basic Information
Clinical ID c3351
Identifier ISRCTN92101486
Trial Title None
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Inflammatory Bowel Disease (IBD), Crohn?s Disease (CD), Ulcerative Colitis (UC) Digestive System Noninfective enteritis and colitis
Interventions The aim of the present study was to investigate clinical effects of the prebiotic lactulose in IBD patients.
Participant Information
Sponsor Solvay Pharmaceuticals GmbH (Germany)
City -
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -